Starting from the fiscal year 2023, C.H. Boehringer Sohn AG & Co. KG reports annually to the German Federal Office for Economic Affairs and Export Control. It describes our human rights due diligence measures in accordance with the German Supply Chain Due Diligence Act (LkSG) in German Language.

Starting from the fiscal year 2023, Boehringer Ingelheim Pharma GmbH & Co. KG reports annually to the German Federal Office for Economic Affairs and Export Control. It describes our human rights due diligence measures in accordance with the German Supply Chain Due Diligence Act (LkSG) in German Language.